Administrative Proceeding File No. 3-20297

Respondents

MJ Biotech, Inc.
Release Date Release Number Other Release Numbers Name of Document
34-104495 Opinion of the Commission
34-102025 Order Requesting Additional Briefing
34-100448 Order Granting Extension of Time
34-98004 Scheduling Order
34-97644 Corrected Order Granting Motion To Set Aside Default and Ordering Briefs
34-92880 Opinion of the Commission
34-92191 Order to Show Cause
34-91850 Order Instituting Administrative Proceedings and Notice of Hearing Pursuant to Section 12(j) of the Securities Exchange Act of 1934
Release Date Release Number Other Release Numbers Name of Document
MJ Biotech Inc.'s Motion to Set Aside Default
Division of Enforcement's Response in Opposition to Respondent's Motion to Set Aside Default with Exhibits 1 and 2
Respondent's Reply to Division of Enforcement's Opposition to Petitioner's Motion to Set Aside Default
Division of Enforcement’s Service Declaration
Division of Enforcement’s Updated Certificate of Service
Order Instituting Administrative Proceedings and Notice of Hearing Pursuant to Section 12(j) of the Securities Exchange Act of 1934
Order to Show Cause
Opinion of the Commission
Joint Mem. Re June 2, 2023 Order
Respondent MJ Biotech, Inc.’s Answer to OIP
Joint Statement Re Prehearing Conference
Division of Enforcement’s Status Report Re Settlement Discussions
Division of Enforcement’s Second Status Report Re Settlement Discussions
Division of Enforcement’s Third Status Report Re Settlement Discussions
Division of Enforcement's Motion for Summary Disposition
Declaration of Rebekah Lindsey in Response to Respondent MJ Biotech Inc.'s Motion to Set Aside Default
Respondent MJ Biotech Inc.’s Cross Motion for Summary Disposition
Division of Enforcement's Brief in Response to Respondent's Cross Motion for Summary Disposition
Order Requesting Additional Briefing
Respondent's MJ Biotech Inc.'s Brief
Division of Enforcement's Brief
Division of Enforcement's Submission of Additional Evidence
Opinion of the Commission

Documents